Racial‒Ethnic Disparities of Buprenorphine and Vivitrol Receipt in Medicaid

Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019

Christine L. Mattson, Lauren J. Tanz, Kelly Quinn et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 1.1K citations · Full text

Pharmacy, Toxicology, Pharmaceutical Toxicology +16

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

Pooja Lagisetty, Ryan Ross, Amy S. B. Bohnert et al. · JAMA Psychiatry · 2019 · 468 citations · Full text

Pharmacy, Pharmaceutical Policy, Pain Management +16

Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States

William C. Goedel, Aaron Shapiro, Magdalena Cerdá et al. · JAMA Network Open · 2020 · 299 citations · Full text

Pharmacy, Community Health, Addiction Psychiatry +13

Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment

Rebecca L. Haffajee, Amy S. B. Bohnert, Pooja Lagisetty · American Journal of Preventive Medicine · 2018 · 255 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacotherapy +17

Methadone as Social Control

Julie Harris, Karen McElrath · Qualitative Health Research · 2012 · 204 citations · Full text

Social Sciences, Health Behavior, Social Psychology +16